Abrogation of p53 function by transfection of HPV16 E6 gene does not enhance resistance of human tumour cells to ionizing radiation

International Journal of Radiation Biology

Volumn 70, Issue 2, 1996, Pages 151-160

  Huang, H ^a   Li, C Y ^a   Little, J B ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RADIOSENSITIVITY; VIRUS GENE; WART VIRUS;

BASE SEQUENCE; GENES, P53; HUMANS; MOLECULAR SEQUENCE DATA; NEOPLASMS; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; RADIATION TOLERANCE; REPRESSOR PROTEINS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0029798427     PISSN: 09553002     EISSN: None     Source Type: Journal    
DOI: 10.1080/095530096145148     Document Type: Article

References (32)

1. BRACHMAN, D. G., BECKFTT, M., GRAVES, D., HARAF, D., VOKES, E. and WEICHSELBAUM, R. R., 1993, p53 mutation does not correlate with radiosensitivity in 24 head and neck cancer cell lines. Cancer Research, 53, 3667-3669.
2. BROWN, R., CLUGSTON, C., BURNS, P., EDLIN, A., VASEY, P., VOHYTESEK, B. and KAYE, S. B., 1993, Increased accumulation of p53 protein in cisplatin-resistant ovarian cell lines. International Journal of Cancer, 55, 678-684.
3. CLARKE, A. R., PURDEI, C. A., HARRISON, D. J., MORRIS, R. G., BIRD, C. C., HOOPER, M. L., and WYLLIE, A. H., 1993, Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature (London), 362, 849-852.
4. CROOK, T., TIDY, J. A., and VOUSDEN, K. H., 1991, Degradation of p53 can be targeted by HPV16 E6 sequences distinct from those required for p53 bidnding and transactivation, Cell, 67, 547-556.
5. DAHLBERG, W. K., LITTLE, J. B., FLETCHER, J. A., SUIT, H. D., and OKUNIEFF, P., 1993, Radiosensitivity, in vitro of human soft tissue sarcoma cell lines and skin fibroblasts derived from the same patients. International Journal of Radiation Biology, 63, 191-198.
6. DILEONARDO, A., LINKE, S. P., CLARKIN, K. and WAHL, G. M., 1994, DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts. Gene and Development, 8, 2540-2551.
7. EL-DEIRY, W. S., HARPER, J. W., O-CONNOR, P. M., VELCULESCU, V. E., CANMAN, C. E., JACKMAN, J., PIETENPOL, J. A., BURRELL, M., HILL, D. E., WANG, Y., WIMAN, K. G., MERCER, W. F., KASTAN, M. B., KOHN, K. W., ELLEDGE, S. J., KINZLER, K. W., and VOGELSTEIN, B., 1994, WAF1/CIP1 is induced in p53-mediated G1 arrest and Apoptosis. Cancer Research, 54, 1169-1174.
8. FAN, S., SMITH, M. L., RIVET, D. J., II, DUBA, D., ZHAN, Q., KOHN, K. W., FORNACE, A. J., JR, and O'CONNOR, P. M., 1995, Disruption of p53 function sensitizes breast cancer MCF-7 cells to cisplatin and pentoxifylline. Cancer Research, 55, 1649-1654.
9. FOSTER, S. A., DEMERS, D. W., ETSCHEID, B. G., and GALLOWAY, D. A., 1994, The ability of papillomavirus E6 proteins to targets p53 for degradation in vivo correlates with their ability to abrogate actinomycin D-induced growth arrest. Journal of Virology, 68, 5698-5705.
10. JUNG, M., NOTARIO, V., and DRITSCHILO, A., 1992, Mutations in the p53 gene in radiation-sensitive and -resistant human squamous carcinoma cells. Cancer Research, 52, 6390-6393.
11. KASTAN, M. B., ONYEKWERE, O., SIDRANSKY, D., VOGELSTEIN, B., and CRAIG, R. W. 1991, Participation of p53 protein in the cellular response to DNA damage. Cancer Research, 51, 6304-6311.
12. LABRECQUE, S., and MATLASHEWSKI, G., 1995, Viability of wild type p53-containing and p53-deficient tumour cells following anticancer treatment: the use of human papillomavirus E6 to target p53. Oncogene, 11, 387-392.
13. LEE, J. M., and BERNSTEIN, A., 1993, p53 mutations increase resistance to ionizing radiation. Proceedings of the National Academy of Science USA, 90, 5742-5746.
14. LI, C. Y., NAGASAWA, H., DAHLBERG, W. K., and LITTLE, J. B., 1995a, Diminished capacity for p53 in mediating a radiation-induced G1 arrest in established human tumor cell lines. Oncogene, 11, 1885-1895.
15. LI, C.-Y., NAGASAWA, H., TSANG, N.-M., and LITTLE, J. B., 1995b, Radiation-induced irreversible G(o)/G(1) block is abolished in human diploid fibroblasts transfected with the human papilloma virus E6 gene: Implication of the p53-Cip/WAF1 pathway. International Journal of Oncology, 6, 233-236.
16. LITTLE, J. B., and NAGASAWA, H., 1985, Effect of confluent holding on potential lethal damage repair, cell cycle progression, and chromosomal aberrations in human normal and ataxia telangiectasia fibroblasts. Radiation Research, 101, 81-93.
17. LITTLE, J. B., and NOVE, J., 1990. Sensitivity of human diploid fibroblast cell strains from various genetic disorders to acute and protracted radiation exposure. Radiation Research, 123, 87-92.
18. 1 arrest in two closely related human lymphoblast cell lines that differ in p53 status. Journal of Biological Chemistry, 270, 11033-11036.
19. LOWE, S. W., BODIS, S., MCCLATCHEY, A., REMINGTON, L., RULEY, H. E., FISHER, D. E., HOUSMAN., and D. E. JACKS, T., 1994, p53 status and the efficacy of cancer therapy in vivo. Science, 266, 807-810.
20. LOWE, S. W., SCHMITT, E. M., SMITH, S. W., OSBORNE, B. A., and JACKS, T., 1993, p53 is required for radiation-induced apoptosis in mouse thymocytes. (Nature London), 362, 847-849.
21. MCILWRATH, A. J., VASEY, P. A., ROSS, and G. M. BROWN, R., 1994, Cell cycle arrests and radiosensitivity of human tumor cell lines: dependence on wild-type p53 radiosensitivity. Cancer Research, 54, 3718-3722.
22. MUNGER, K., SCHEFFNER, M., HUIBREGTSE, J. M., and HOWLEY, P. M., 1992, Interactions of HPV E6 and E7 oncoproteins with tumor suppressor gene products. Cancer Surveys, 12, 197-217.
23. NAGASAWA, H., and LITTLE, J. B., 1983, Comparison of kinetics of X-ray-induced cell killing in normal, ataxia telangiectasia and hereditary retinoblastoma fibroblasts. Mutation Research, 109, 297-308.
24. NAGASAWA, H., LI, C.-Y., MAKI, C. G., IMRICH, A. C., and LITTLE, J. B., 1995, Relationship between radiation-induced G1 phase arrest and p53 function in human tumor cells. Cancer Research, 55, 1842-1846.
25. O'CONNOR, P. M., JACKMAN, J., JONDLE, D., BHATIA, K., MAGRATH, I., and KOHN, K. W., 1993, Role of the p53 tumor suppressor gene in cell cycle arrest and radiosensitivity of Burkitt's lymphoma cell lines. Cancer Research, 53, 4776-4780.
26. SAMBROOK, J., FRITSCH, E. F., and MANIATIS, Y., 1989, Molecular Cloning: A Laboratory Manual, 2nd edn (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York).
27. SCHEFFNER, M., WERNESS, B. A., HUIEBREGTSE, J. M., LEVINE, A. J., and HOWLEY, P. M., 1990, The 6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell, 63, 1129-1136.
28. SHEW, J.-Y., LIN, B. T.-Y., CHEN, P.-L., TSENG, B. Y., YANG-FENG, T. L., and LEE, W.-H., 1990, C-terminal truncation of the restinoblastoma gene product leads to functional inactivation. Proceedings of the National Academy of Sciences, USA, 87, 6-10.
29. SLICHENMYER, W. J., NELSON, W. G., SLEBOS, R. J., and KASTAN, M. B., 1993, Loss of a p53-associated G1 checkpoint does not decrease cell survival following DNA damage. Cancer Research, 53, 4164-4168.
30. SU, L-N., and LITTLE, J. B., 1992, Transformation and radiosensitivity of human diploid skin fibroblasts transfected with SV40 T-antigen mutants defective in RB and p53 binding domains. International Journal of Radiation Biology, 62, 461-468.
31. TSANG, N.-M., NAGASAWA, H., LI, C.-Y., and LITTLE, J. B., 1995, Abrogation of p53 function by transfection of HPV16 E6 gene enhances the resistance of human fibroblasts to ionizing radiation. Oncogene, 10, 2403-2408.
32. WEICHSELBAUM, R. R., DAHLBERG, W., and LITTLE, J. B., 1985, Inherently radioresistant cells exist in some human tumors. Proceedings of the National Academy of Sciences, USA, 82, 4732-4735.